Remove Bioavailability Remove FDA Approval Remove Gene Silencing Remove Production
article thumbnail

Vevye: A New Cyclosporine Solution for Dry Eye Disease

XTalks

Novaliq, a biopharmaceutical company specializing in ocular therapeutics, recently announced that their product Vevye (cyclosporine ophthalmic solution) 0.1 percent received approval from the US Food and Drug Administration (FDA) to treat dry eye disease. This mechanism reduces eye swelling and promotes tear production.